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Review article
Ανασκόπηση
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   Πρωτεΐνες οξείας φάσης: νέα δεδομένα για τη διαγνωστική τους αξία στην 
κτηνιατρική εργαστηριακή διάγνωση
Cerón JJ1, Martinez-Subiela S1, Tecles F1, Caldin M2
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AbstrAct
The objective of this review is to provide updated information about how acute phase proteins (APPs) can be used in the process 
of diagnosis in veterinary medicine. For this purpose, recommendations about assay methodologies and basic principles regard-
ing clinical application of APPs will be provided. In addition, the use of APPs for (1) the detection and quantification of inflam-
matory response, (2) the diagnosis of the underlying etiology and (3) the detection of selected non-inflammatory processes will 
be reviewed with practical examples.
Keywords: acute phase proteins, cat, diagnosis, dog
ΠΕΡΙΛΗΨΗ
Στην ανασκόπηση αυτή αναφέρονται τα νεότερα δεδομένα σχετικά με τη σημασία των πρωτεϊνών οξείας φάσης (ΠΟΦ) στη 
διαγνωστική διερεύνηση των νοσημάτων του σκύλου και της γάτας. Για το σκοπό αυτό γίνεται λεπτομερής αναφορά στη δια-
γνωστική αξία και την προτεινόμενη μεθοδολογία για τη μέτρηση των ΠΟΦ. Παράλληλα περιγράφεται με τη βοήθεια παραδειγ-
μάτων από την κλινική πράξη η σημασία της μέτρησης των ΠΟΦ για τη διάγνωση και τη διαφορική διάγνωση των νοσημάτων 
του σκύλου και της γάτας.
Λέξεις ευρετηρίασης: γάτα, εργαστηριακή διάγνωση, πρωτεΐνες οξείας φάσης, σκύλος
http://epublishing.ekt.gr | e-Publisher: EKT | Downloaded at 21/02/2020 00:07:17 |
J HELLENIC VET MED SOC 2014, 65(3)
ΠΕΚΕ 2014, 65(3)
198 CEróN JJ, MArTINEz-SUbIELA S, TECLES F, CALDIN M
IntroductIon
Acute phase proteins (APPs) are serum pro-teins whose concentration changes in re-
sponse to  inflammation or stimulation of the 
immune system regardless of the inciting cause. 
APPs may either increase (positive APPs) or de-
crease (negative APPs) in the course of disease 
(Cerón et al., 2005). Positive APPs may be fur-
ther classified into two groups:
   Major  positive APPs, such as C-reactive protein 
(CrP) in the dog or serum amyloid A (SAA) in 
the cat. Usually they are virtually undetectable in 
the blood of healthy animals, but their concentra-
tion can increase between 10-1000 times upon 
stimulation. 
   Moderate APPs, such as haptoglobin (Hp) or 
fibrinogen. They are present in the blood of 
healthy animals but may increase 2-10 fold in 
concentration following stimulation.
Major APPs show an early and high rise in concen-
tration and a very rapid decline, whereas moderate 
APPs need more time to increase and return to nor-
mal values. An example of negative APPs is albumin 
that, since it is the most abundant protein in serum, 
decreases to promote the synthesis of other proteins 
related with inflammation.
APPs are generated in a fast reaction, that usually 
in the case of major APPs develops within hours 
(i.e., CrP showed significant increases 4 hours after 
a surgical trauma) and reaches peak concentrations 
in approximately 24 hours. This reaction starts as 
a sequela to any injury and is part of the innate 
immune response. In this sense APPs differ from 
immunoglobulins (Igs), which are involved in the 
acquired immune response, in two main aspects 
(Cerón, 2013):
   APPs are non-specific proteins since they are 
produced by any process that damages the organ-
ism, whereas Igs are specific against a selected 
pathogen.
   The production of APPs is very fast, appearing 
within hours, whereas in general Igs synthesis is 
evident at least after one-two weeks (seroconver-
sion).
During the previous decade there has been a grow-
ing interest about the use of APPs in routine prac-
tice in companion animals, with their inclusion in 
routine biochemical profiles in several diagnostic 
laboratories all over the world. General guidelines 
have been published about the interpretation of APPs 
changes which contributed to their practical appli-
cation  (Cerón et al., 2008). Our experience after 
many years of studying these biomarkers, is that 
practitioners who regularly use APPs analysis tend 
to rely on these proteins as one of the most important 
biomarkers of inflammation and use them satisfac-
torily in many clinical situations for the diagnosis, 
treatment monitoring and predicting the outcome of 
inflammatory diseases. In this review we will try to 
focus on providing updated information and practi-
cal examples about how APPs can be used in the 
process of diagnosis. Although, due to their lack of 
specificity, APPs will have obvious limitations, there 
are a number of clinical situations in which APPs 
can provide valuable information in the diagnosis. In 
addition, since accurate measurements of APPs are 
crucial for an appropriate interpretation in diagnos-
tics we will also deal with this topic in this review.
 
How to meAsure APPs
The acute phase protein tests may not be valid if run 
in a human laboratory or with human assays unless 
each assay is validated for the species being tested. 
The validation procedure should be repeated for each 
new batch of antiserum (Eckersall et al., 1999; Cerón 
et al., 2005). The dog and cat proteins have variable 
cross reactivities to antisera against human proteins, 
different reaction profiles and different reference 
ranges, thus some human assays are not suitable for 
use in dogs or cats (Fransson et al., 2007).
In addition it is recommended that working standards 
(purified protein or pools of acute phase serum) and 
control samples should be matched with the spe-
cies under investigation (Eckersall, 1995). The use 
of specific species standards implies obtaining  a 
similar affinity of antiserum against standards and 
samples, giving more accurate measurements, and 
also produces wider analytical ranges, avoiding the 
need for the dilution of samples (Tecles et al., 2007). 
Calibration of assay methods ideally should be har-
http://epublishing.ekt.gr | e-Publisher: EKT | Downloaded at 21/02/2020 00:07:17 |
J HELLENIC VET MED SOC 2014, 65(3)
ΠΕΚΕ 2014, 65(3)
CEróN JJ, MArTINEz-SUbIELA S, TECLES F, CALDIN M                   199
and moderate APPs and a decrease in albumin (nega-
tive APP). It should be pointed out that in pregnant 
bitches an acute phase response with increases in 
CrP and Hp occurs at 21 days after fertilization, 
coinciding with embryonic implantation (Eckershall 
et al., 1993).
tHe use of APPs In tHe detectIon And 
quAntIfIcAtIon of InflAmmAtory 
resPonse 
Although APPs should be used and interpreted 
together with the total blood cell counts (CbC) data, 
they have several advantages compared to the meas-
urement of  white blood cell counts (WbC) to detect 
inflammation such as:
   APPs are more sensitive, especially in cases 
of mild or chronic inflammation. Moreover, in 
cases of severe and acute inflammation, such as 
babesiosis, the diagnostic sensitivity of CrP was 
significantly higher compared to WbC counts 
(Matijatko et al., 2007). Similarly, CrP was 
more useful than the WbC counts for assessing 
the severity of inflammation in different surgical 
procedures (Yamamoto et al., 1993).
   APPs are more stable than cells and measure-
ments can be made in frozen serum samples.
   APPs detect inflammation in cases with suppres-
sion or decreased activity of the bone marrow. 
   APPs quantify the magnitude of  the inflammato-
ry response in situations of severe inflammation 
where is a decrease in WbC.
 This high sensitivity and fast stimulation of response 
allow APPs to detect subclinical inflammation, with 
changes in APPs occurring before the presence of 
clinical sigs. Therefore APPs are ideal for routine 
health checks, since an increase in APPs in an appar-
ently healthy animal can indicate the presence of 
a subclinical disease or be predictive of an active 
disease developing in the near future. Suzuki et al. 
(2007) reported cases of dogs infected with Babesia 
gibsoni where high concentrations of CrP were doc-
umented despite the absence of obvious clinical signs 
or parasitemia. Also high values of CrP were also 
found in asymptomatic dogs infected by Leishmania 
infantum (Martinez-Subiela et al., 2002)
monized to ensure that results obtained in different 
laboratories are comparable universally and of con-
sistent quality (Cerón et al., 2005). It is encouraging 
to note that very similar cut-off points for APPs in 
selected canine diseases have been established at dif-
ferent laboratories (Kocaturk et al., 2010; McClure et 
al., 2013).
recently a series of point-of-care equipment for 
APPs measurements in veterinary medicine have 
been developed. These devices should be used only 
if adequately validated, and the need of having a spe-
cial care should be stressed at this point. The authors 
have found that certain equipments do not have an 
adequate accuracy and precision in contradiction with 
published data or the “official” data that the manufac-
turer of the equipment provides.
Usually for most APPs, serum, EDTA or heparinised 
plasma (with exception of fibrinogen that needs plas-
ma samples) can be used. It is important to know the 
effect of hemolysis, lipemia and bilirubinemia in the 
assay used for APPs measurement. APPs are fairly 
stable and the samples can be kept refrigerated for 
several days or frozen for long period preservation 
(Cerón et al., 2005).
bAsIc AsPects for use of 
APPs In dIAgnostIcs
For diagnostic use it would be recommended to use a 
profile of APPs including at least:
   one major acute phase protein (APP) such as CrP 
in the dog or SAA in the cat. SAA can be also 
used in the dog, however the lack of automated 
or point-of-care analysers for SAA measurements 
in dog has limited its application. CrP does not 
function as a major APP in the cat.
   one moderate APP such as haptoglobin or fibrino-
gen.
   one negative APP such as albumin.
The reference values currently used in the authors’ 
laboratory for the main APPs are:
-Canine C-reactive protein: <12  mg/L
-Feline serum amyloid A: < 1 mg/L 
-Canine and feline haptoglobin: < 3g/L
-Fibrinogen:1-3 g/L
In inflammation there is an increase in both major 
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In addition to their use in detecting inflammation, 
APPs can be used for quantification of its magnitude. 
This can help to evaluate the severity of the disease 
as well the presence of complications. Some relevant 
examples include:
   Higher mean CrP and Hp values were found 
in dogs infected with Ehrlichia canis that had 
myelosuppression, compared to those with the 
uncomplicated disease (mean CrP and Hp val-
ues of 237.3 mg/l and 4.15 g/L, respectively, 
were documented in myelosuppressed compared 
to 144.2 mg/L and 1.96 g/L in the uncompli-
cated cases). This would  probably reflect a more 
severe tissue damage and inflammatory reaction. 
Interestingly there were no significant differences 
in serum albumin. Therefore these positive APPs 
can be useful in assessing the clinical severity 
of canine monocytic ehrlichiosis, in association 
with other clinicopathological tests such as CbC 
or traditional serum biochemistry (Mylonakis et 
al., 2011).  
   CrP has been proposed as a useful laboratory 
marker to assess the inflammatory process 
associated with inflammatory bowel disease 
(IbD) in dogs. Although CrP changes are not 
very pronounced and barely exceed the reference 
range established by many laboratories, increases 
in this APP (mean values of 15.33 mg/L) have 
been found in dogs with IbD that have active 
disease and overt gastrointestinal signs such 
as weight loss, vomiting, diarrhea, melena or 
tenesmus, and CrP values were strongly 
correlated with disease activity (Jergens et al., 
2003).
   There is an evident acute phase response in 
dogs with generalized demodicosis, showing 
median values of CrP of 51.7 mg/L, which does 
not occur in the localized form. Measurements 
of CrP could therefore provide an aid to 
clinicians in deciding whether doubtful cases 
could be considered as generalized or localized, 
because values outside the reference range of the 
laboratory could be suggestive of the generalized 
form (Martinez Subiela et al., 2014). 
   In mammary tumors, CrP showed major 
increases (mean values of 86.1 mg/L) in those 
with histologic evidence of malignancy and 
metastasis, compared to benign or non-metastatic 
malignant tumours (mean CrP values of 9.45 
and 6.10 mg/L respectively) (Tecles et al., 
2009). Therefore major increases of CrP in dogs 
with mammary tumours, in absence of evident 
inflammatory conditions, could be considered as 
an indicator of metastasis. 
   APPs can be used to quantify inflammation 
associated with surgery. The magnitude of 
CrP increases in dogs subjected to surgery is 
generally related to the intensity of the surgical 
trauma. For example, in an study in which 
different surgical procedures were compared, 
CrP increase was more pronounced when severe 
tissue injury was inflicted in muscle or bone 
tissue by procedures such as orthopaedic surgery 
(Yamamoto et al., 1993). 
APPs As A dIAgnostIc AId In tHe  
etIologIc dIAgnosIs of  InflAmmAtIon
APPs are not useful in the direct etiologic diagnosis 
of inflammation but, the magnitude of their increase 
can be informative (Table 1). Furthermore, it may 
help to reduce the list of diagnosis differentials in 
some situations as described below:
   Marked increases of serum CrP concentration 
(higher than 100 mg/L) can raise the suspicion 
of systemic inflammatory response syndrome 
(SIrS) (associated with sepsis and a positive 
result of bacterial culture of appropriate samples) 
or an immune-mediated disorder. Some examples 
could be:
         -In dogs with clinical signs compatible with 
respiratory diseases, bacterial pneumonia was 
identified with a specificity of 100% when CrP was 
higher than 100 mg/L, compared to other respiratory 
diseases/syndromes had significantly lower CrP 
values, such as bacterial tracheobronchitis (23 
mg/L), chronic bronchitis (13 mg/L), eosinophilic 
bronchopneumonitis (5 mg/L), canine idiopathic 
pulmonary fibrosis (17 mg/L) and cardiogenic 
pulmonary edema (19 mg/L) (Viitanen et al., 2013).     
         -Dogs with autoimmune haemolytic anaemia 
had high CrP values early in the course of disease 
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infectious–inflammatory cause. For example:
         - In cases of lameness, CrP can facilitate the 
differential diagnosis between immune-mediated 
polyarthritis that usually is characterized by major 
increases in this APP, and other conditions such 
as degenerative joint disease or intervertebral disk 
displacement that do not affect CrP values (Ohno et 
al., 2006). 
        -In dogs with compatible neurological signs, 
the presence of a marked increase in serum CrP 
(that usually is not accompanied by changes in CbC) 
may support the diagnosis of steroid responsive 
meningit is-arteri t is  (SrMA), versus other 
differential diagnoses such as meningoencephalitis, 
intervertebral disk disease, degenerative lumbosacral 
stenosis, central nervous system neoplasia or 
idiopathic epilepsy, that do not produce major 
increases in serum CrP (bathen-Noethen et al., 
2008). 
(mean 191.2 mg/L) (Mitchell et al., 2009). Therefore, 
the concurrent presence of a severe anemia and 
elevated CrP values could be indicative of an 
immune-mediated mechanism for this anemia. 
         -Gastrointestinal disease usually produces 
very mild changes in CrP that does not exceed 21.5 
mg/l (McCann et al., 2008).  And in viral infections 
the acute-phase response is generally moderate or 
mild; for example, in human beings, CrP values of 
20-39 mg/L have been reported for viral infections 
(Hjortdahl et al., 1991). Therefore, a major increase 
in CrP in a dog with parvovirus infection could 
indicate septicemia associated with the compromise 
of normal protective intestinal barriers (Kocaturk et 
al., 2010). 
   In conditions where clinical signs could be 
produced by multiple inflammatory or non-
inflammatory causes, the presence of a 
positive APP profile raises the suspicion for an 
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table 1. A guide for clinical interpretation of the magnitude of serum CrP increase in dogs
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APPs As A dIAgnostIc AId In tHe 
detectIon of non-InflAmmAtory 
Processes 
The divergence between the evolution patterns of 
major and moderate APPs  could help to detect dis-
ease processes not associated with inflammation. The 
term “divergence” is used to describe the situation in 
which APPs of both groups do not change in a simi-
lar and proportional manner as should occur when 
there is an inflammatory stimulus. Some relevant 
examples are listed below:
   An increase in Hp concentration with normal 
CrP values in a dog with no history of gluco-
corticoid treatment could indicate the increase 
production of endogenous steroids, as in hyper-
adrenocorticism. This is due to the fact that glu-
cocorticoids stimulate increases in haptoglobin 
and decreases in CrP (Caldin et al., 2009). This 
particular profile can potentially be used as an 
indication of canine hyperadrenocorticism. Also 
if in a dog diagnosed with hyperadrenocorti-
cism there is an increase in CrP, it will imply 
the presence of a severe inflammatory stimulus 
that is able to overcome the inhibitory effect 
of steroids. Therefore the clinician should look 
for inflammatory complications such as severe 
sepsis, urinary infection, deep pyoderma, severe 
mastitis or immune-mediated haemolytic anemia 
(Caldin et al., 2009)
   A decrease in Hp with increased CrP could sug-
gest haemolysis or internal haemorrhage leading 
to haemolysis. This is because one of the main 
functions of Hp is to link to haemoglobin upon 
its release from damaged erythrocytes to facili-
tate its degradation and avoid the oxidative stress 
caused by haemoglobin. For example, in 50 dogs 
naturally infected by B. canis,  CrP concentra-
tion were found to increase (mean values of 170 
mg/L)  while haptoglobin remained within refer-
ence ranges (mean values of 2.7 g/L). These nor-
mal values of haptoglobin could reflect the mixed 
effect of inflammation,  associated with moderate 
increases, and haemolysis which reduces the hap-
toglobin concentration (Matijatko et al., 2007).
    -CrP together with the percentage of band 
neutrophils has been proposed as laboratory marker 
in order to differentiate pyometra and cystic 
endometrial hyperplasia/mucometra (CEH). CEH is 
not associated with bacterial infection, and  a mucus 
material is accumulated in the uterus instead of the 
purulent material that appears in pyometra. A mean 
of 12.5 % band neutrophils  versus 1.69 % and a 
CrP concentration of 200 versus 53 mg/L were 
found in pyometra versus CEH cases in a previous 
study (Fransson et al., 2004).
  Nevertheless, in other situations such as nasal dis-
eases, it seems that CrP does not help to differenti-
ate the cause of the problem. Similar changes in 
CrP values have been noted in aspergillosis, non-
specific rhinitis or neoplasia (Sheahan et al., 2010). 
In these cases CrP changes were not pronounced, 
so a marked elevation in this APPs in cases of nasal 
disease should prompt the clinician to look for con-
current or underlying inflammatory pathology that 
may be of clinical significance. In addition CrP does 
not appear to be useful for differentiating among 
causes of canine chronic gastrointestinal disease such 
as inflammatory bowel disease, parasitic infections, 
dietary and antibiotic responsive diarrhoea diarrhea, 
gastrointestinal neoplasia or presumed motility dis-
orders (Mc Cann et al, 2008). Also, intestinal malab-
sorption caused by exocrine pancreatic insufficiency, 
wheat-sensitive enteropathy or anaerobic bacterial 
overgrowth did not produce increases in CrP in dogs 
(Caspi et al., 1987). So if there is an evident increase 
in CrP associated with any of these conditions it 
will indicate the presence of a complicating systemic 
inflammatory condition.
   In cats SAA and AGP has been demonstrated to be 
a reliable aid in the diagnosis of FIP,  because major 
increases in both APPs are associated with this con-
dition (Duthie et al., 1997; Giordano et al., 2004). 
However, the concurrent increase of both APPs are 
not pathognomonic for this disease because it can be 
also found in other conditions such as septic proc-
esses or disseminated neoplasias (Hazuchova et al., 
2012).
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conclusIons
Despite the limitations associated to their lack of 
specificity, APPs can be used in selected situations 
as a valuable diagnostic tool. It is expected that the 
information presented in this paper can be helpful for 
practitioners who are already using these biomarkers 
and further encourage others not familiar with their 
applications to use them for clinical diagnosis. 
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